製品: SERPINA3 Antibody
カタログ: DF6185
タンパク質の説明: Rabbit polyclonal antibody to SERPINA3
アプリケーション: WB IHC
反応性: Human, Mouse, Rat
予測: Rabbit
分子量: 48kDa; 48kD(Calculated).
ユニプロット: P01011
RRID: AB_2838151

類似製品を見る>>

   サイズ 価格 在庫状況
 100ul $280 在庫あり
 200ul $350 在庫あり

リードタイム: 当日配達

For pricing and ordering contact:
お問い合わせ先

製品説明

ソース:
Rabbit
アプリケーション:
WB 1:500-1:2000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

反応性:
Human,Mouse,Rat
予測:
Rabbit(80%)
クローナリティ:
Polyclonal
特異性:
SERPINA3 Antibody detects endogenous levels of total SERPINA3.
RRID:
AB_2838151
引用形式: Affinity Biosciences Cat# DF6185, RRID:AB_2838151.
コンジュゲート:
Unconjugated.
精製:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:

折りたたみ/展開

SERPINA3; AACT; AACT_HUMAN; ACT; Alpha-1-antichymotrypsin His-Pro-less; Antichymotrypsin; Cell growth inhibiting gene 24/25 protein; Cell growth-inhibiting gene 24/25 protein; GIG24; GIG25; Growth inhibiting protein 24; Growth inhibiting protein 25; MGC88254; Serine (or cysteine) proteinase inhibitor clade A (alpha 1 antiproteinase, antitrypsin) member 3; Serine (or cysteine) proteinase inhibitor clade A member 3; Serine proteinase inhibitor clade A member 3; Serpin A3; Serpin family A member 3; Serpin peptidase inhibitor clade A (alpha 1 antiproteinase antitrypsin) member 3; SERPINA3;

免疫原

免疫原:
Uniprot:
遺伝子(ID):
発現特異性:
P01011 AACT_HUMAN:

Plasma. Synthesized in the liver. Like the related alpha-1-antitrypsin, its concentration increases in the acute phase of inflammation or infection. Found in the amyloid plaques from the hippocampus of Alzheimer disease brains.

タンパク質の説明:
The protein encoded by this gene is a plasma protease inhibitor and member of the serine protease inhibitor class. Polymorphisms in this protein appear to be tissue specific and influence protease targeting. Variations in this protein's sequence have been implicated in Alzheimer's disease, and deficiency of this protein has been associated with liver disease. Mutations have been identified in patients with Parkinson disease and chronic obstructive pulmonary disease. [provided by RefSeq, Jul 2008]
タンパク質配列:
MERMLPLLALGLLAAGFCPAVLCHPNSPLDEENLTQENQDRGTHVDLGLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGNASALFILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLLSALVETRTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPKQA

種類予測

種類予測:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Rabbit
80
Horse
70
Dog
70
Xenopus
67
Bovine
44
Pig
0
Sheep
0
Zebrafish
0
Chicken
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

PTMs - P01011 基板として

Site PTM Type Enzyme
N33 N-Glycosylation
T35 Phosphorylation
N93 N-Glycosylation
N106 N-Glycosylation
N127 N-Glycosylation
K158 Acetylation
K177 Acetylation
N186 N-Glycosylation
K191 Acetylation
S201 Phosphorylation
T203 Phosphorylation
K235 Acetylation
K236 Acetylation
K237 Acetylation
C261 S-Nitrosylation
N271 N-Glycosylation
S273 Phosphorylation
T295 Phosphorylation
S302 Phosphorylation
T338 Phosphorylation
T347 O-Glycosylation
T347 Phosphorylation
S384 Phosphorylation
K416 Acetylation
K421 Acetylation

研究背景

機能:

Although its physiological function is unclear, it can inhibit neutrophil cathepsin G and mast cell chymase, both of which can convert angiotensin-1 to the active angiotensin-2.

PTMs:

N- and O-glycosylated.

細胞の位置付け:

Secreted.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
組織特異性:

Plasma. Synthesized in the liver. Like the related alpha-1-antitrypsin, its concentration increases in the acute phase of inflammation or infection. Found in the amyloid plaques from the hippocampus of Alzheimer disease brains.

サブユニット構造:

Interacts with DNAJC1.

タンパク質ファミリー:

The reactive center loop (RCL) extends out from the body of the protein and directs binding to the target protease. The protease cleaves the serpin at the reactive site within the RCL, establishing a covalent linkage between the carboxyl group of the serpin reactive site and the serine hydroxyl of the protease. The resulting inactive serpin-protease complex is highly stable.

Belongs to the serpin family.

参考文献

1). Serpina3n/serpina3 alleviates cyclophosphamide-induced interstitial cystitis by activating the Wnt/β-catenin signal. International Urology and Nephrology, 2023 (PubMed: 37594700) [IF=2.0]

Application: WB    Species: Human    Sample:

Fig. 1 Serpina3/serpina3n expression was down-regulated in IC/BPS. A Assessment of the pathological changes in human bladder tissues by HE staining (× 200). B Evaluation of mast-cell infiltration in human bladder tissues using toluidine blue staining (× 200). C, D The mRNA and protein levels of serpina3 in the bladder tissues from IC/BPS patients and healthy individuals were tested by qPCR and western blotting. E Assessment of the pathological changes in mouse bladder tissues by HE staining (× 200). F Evaluation of mast-cell infiltration in mouse bladder tissues using toluidine blue staining (× 200). G, H The mRNA and protein levels of serpina3 in the bladder tissues from IC/BPS patients and healthy individuals were tested by qPCR and western blotting. (*P 

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.